Navigation Links
Addrenex Pharmaceuticals' New Hires Further Company Goal to Identify New Drugs for Adrenergic Regulation
Date:8/19/2008

fluctuations and myriad environmental factors.

To identify new drug candidates, Addrenex will delve into its vast library of 400 adrenergic compounds, housed at the University of Nebraska Medical Center. Addrenex licensed the rights to the portfolio in December, and the company has already produced a new drug candidate-ADX415-from the portfolio. The new compound will be developed for the treatment of hypertension and other potential indications.

Bream will work with University of Nebraska scientists to further analyze various compounds for their affinity to alpha-2 adrenergic receptors and subreceptors that might enhance efficacy or reduce side effects of current alpha-2 compounds. He will be responsible for advancing several drug candidates through the preclinical and early clinical phases.

Butts will work in tandem with the scientific group to identify indications where Addrenex can fill an unmet medical need, Khayrallah said. His expertise in commercializing drugs will help prioritize the most viable drug candidates in the pipeline. Butts will also oversee commercial efforts in the company's current and future partnerships.

"The convergence of commercial and scientific expertise is essential to optimizing our portfolio of drugs," said Khayrallah. "We're now in a position to carefully assess which compounds and which receptors are the best targets for addressing a desired indication."

Gary Bream

Gary Bream brings to Addrenex a decade of regulatory affairs experience and 11 years of clinical research experience. Bream most recently served as senior director of regulatory affairs and strategic drug development services at Constella Group. He also served in the areas of regulatory affairs, clinical operations and clinical research at Constella, formerly Lineberry Research Associates and now SRA International. Bream's career includes scientific positions at Merck Research Laboratories in West Point, PA, and at Burroughs Wellc
'/>"/>

SOURCE Addrenex Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Vion Pharmaceuticals Enters Into Agreement With HOVON to Conduct a Phase III Clinical Trial of Cloretazine(R) in Combination With Frontline AML and MDS Therapy
2. Oramed Pharmaceuticals Chosen to Present Oral Insulin Trial Results at EASD Conference (September 7-11, Rome)
3. Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
4. Oramed Pharmaceuticals Announces Successful Phase 2A Clinical Trial of its Oral Insulin Capsule
5. Rib-X Pharmaceuticals, Inc. Announces Recent and Upcoming Presentations at Scientific Conferences
6. Oramed Pharmaceuticals to Hold Conference Call on August 6 to Present Results of Phase 2A Oral Insulin Capsule Clinical Trials
7. Quark Pharmaceuticals Announces First Patient Dosing by Pfizer in Phase II Trial of RNAi Therapy in Diabetic Macular Edema
8. Idenix Pharmaceuticals Advances HCV Discovery Program to Clinic
9. Celator Pharmaceuticals Raises Series C Financing in Excess of $22.5 Million
10. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2008 Financial Results and Provide a Clinical Program Update on August 7, 2008
11. Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2008)...W YORK, Nov. 20 Clinical data from...e 35th Annual Veith Symposium shows DVT,treatment...om Bacchus,Vascular, Inc. (Santa Clara, CA) succe... in about 20 minutes. , This technique, cal...ores,blood flow more quickly and safely than curr...
(Date:11/19/2008)...N FRANCISCO, Nov. 19 Posit Science...idence at the Society for Neuroscience,Annual Con...t cognitive,training may benefit Baby Boomers. T...ess Program (TM) uses adaptive exercises that targ...are designed to drive generalized,improvements in...
(Date:11/19/2008).... Jude scientists report basic findings on critica...g how to better treat an array of disorders , ...e/ -- Scientists at St. Jude Children,s Research ...of one of the body,s enzyme workhorses called calp...evers, calpains function in many cellular processe...
(Date:11/19/2008)...riggers $5 Million Payment from Roche- , , ...Memory Pharmaceuticals Corp. (Nasdaq: MEMY ) tod...oal for its Phase 2 trial of R3487/MEM 3454, its l...ve impairment associated with schizophrenia (CIAS)...Phase 2 trial, triggering a $5.0 million payment f...
Breaking Medicine Technology:Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 2Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 3New Evidence That Brain-Plasticity Based Training has Broad Impact: Improved Cognition in Boomers, Improved Motor Control in Older Adults 2New Insight Into the Controls on a Go-To Enzyme 2New Insight Into the Controls on a Go-To Enzyme 3Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 3MedCath Corporation to Present at the BMO Capital Markets 2007 Focus on Healthcare Conference 7180 1CEVA Group Plc Reports Quarter 3 2007 Results 7176 1CEVA Group Plc Reports Quarter 3 2007 Results 7176 2CEVA Group Plc Reports Quarter 3 2007 Results 7176 3CEVA Group Plc Reports Quarter 3 2007 Results 7176 4Finding Ways for Seniors to Stay Safe Healthy and Home 7172 1Finding Ways for Seniors to Stay Safe Healthy and Home 7172 2Finding Ways for Seniors to Stay Safe Healthy and Home 7172 3First European Patient Treated in CABERNET Trial With Novel Treatment for Wet AMD 1993 1First European Patient Treated in CABERNET Trial With Novel Treatment for Wet AMD 1993 2First European Patient Treated in CABERNET Trial With Novel Treatment for Wet AMD 1993 3
...007 - Xanthus,Pharmaceuticals, Inc today presented...clinical and pathological signs of chronic,disease...esentation,was made by Stephen J. Karlik, Ph.D., P... of Western Ontario, London, Ontario,together wit...the,59th American Academy of Neurology Meeting in ...
...nical (IND) In- Vitro,Studies for Promising Alzhei...) -- Samaritan,Pharmaceuticals Inc. (AMEX:LIV), a ...nce positive results were attained with its,late-s...l (SP-233),with well recognized in-vitro models. ...ect predictors,of clinical responses, laboratory a...
Other Medicine Technology:Xanthus Presents Novel Approach for Autoimmune Disease Reversal,with Symadex 2Xanthus Presents Novel Approach for Autoimmune Disease Reversal,with Symadex 3Samaritan Announces Positive Data in Nonclinical (IND) In-Vitro,Studies for Promising Alzheimer's Drug 2Samaritan Announces Positive Data in Nonclinical (IND) In-Vitro,Studies for Promising Alzheimer's Drug 3
(Date:11/22/2008)...o enough to protect themselves from stroke, heart ...News) -- It,s one of medicine,s mantras: If you ha...ill have a dramatic impact on your risk of stroke,...ople with high blood pressure still aren,t doing a...S. Centers for Disease Control and Prevention stud...
(Date:11/21/2008)... new therapies for preterm labor , , FRI...hey,ve found the switch that activates the uterine...ing that may lead to therapies for preterm labor. ... protein IP on the surface of these uterine muscle...egnancy. , But researchers from Dartmouth Medi...
(Date:11/21/2008)...v. 21 During a memoria... G. Rendell today remembered Lieutenant Governor C...ortant partner in public service, and a tireless a... "As the first woman elected lieutenant governor, ... said Governor Rendell. "Her family and her faith ...
(Date:11/21/2008)...l proved effective against Lennox-Gastaut syndrome... A new drug called Banzel (rufinamide) has been ap...orm of epilepsy called Lennox-Gastaut syndrome, th...ay. , The approval was based on results of a fo...s 4 to 30. Compared to patients who took a placebo...
Breaking Medicine News(10 mins):Health News:High Blood Pressure Stalks Many Americans 2Health News:High Blood Pressure Stalks Many Americans 3Health News:Pennsylvania Governor Rendell Remembers, Celebrates the Life of Lt. Governor Catherine Baker Knoll During Capitol Tribute 2Health News:Pennsylvania Governor Rendell Remembers, Celebrates the Life of Lt. Governor Catherine Baker Knoll During Capitol Tribute 3Health News:FDA Approves New Drug for Severe Epilepsy 2
...AIDS in the early 1990's when she was 35, healthy,...d years earlier// of AIDS related complications, h...her less than two years to live. One day, flippi...eople, she saw an advertisement offering to buy he...
...a close friend of President Bush, a businessman-...itchman// on the president's health care proposals...th costs. He is promoting Bush's proposals to prov...... and make hospitals and doctors prices availabl...
...atisfied with their health care despite the fact t... other industrialized nations//. These were the re...d on Tuesday. In 2004 the survey revealed that Un... on medical care almost twice as much as other ind...
...iting crowd of 80,000 and the humid weather, the f... can feel cheerful about here are a spruced up// a...one-day cricket match between England and India ta...ernational Stadium Thursday. The teams were given ...
Other Medicine News:
The NU-5510 DHD AutoFlow Direct Heat Decontamination CO2 Incubator provides continuous HEPA filtration guarantying the greatest control of airborne contaminants. The dual decontamination cycles, both
...al-sized CO2 incubator with 6-sided direct heating...er-weight incubator with greater internal storage ...ss, convection air circulation optimizes culture c...al viewing window means cultures need not be distu...
...te-sized CO2 incubator with 6-sided direct heating...er-weight incubator with greater internal storage ...filtered CO2 inlet, heated outer door with glass i... optimize culture conditions and minimize contamin...
IR Autoflow Dual Chamber Over-Under Water-Jacketed CO2 Incubator
Medicine Products: